Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Glenmark Pharma has been in a trading range but every time it dips, there are buyers and it does appear that it is willing to breakout of that range and move towards new highs. That is a buying opportunity." "The second is Apollo Hospitals, now this has been in a deep correction and a strong underperformer, a distinct underperformer. That is coming to an end now, so we are buying on a big correction almost at the lows of that correction. It is a nice place to be in, so both are buying ideas," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!